Cigna earnings beat by $0.04, revenue topped estimates
Mary A. Tidlund, a director at CompX International Inc. (NYSE:CIX), recently sold 1,000 shares of the company's Class A common stock. The transaction, which took place on November 14, 2024, was executed at an average price of $29.0213 per share, amounting to a total value of approximately $29,021. Following this sale, Tidlund holds 5,650 shares directly. The sale was reported in a Form 4 filing with the Securities and Exchange Commission.
InvestingPro Insights
While Mary A. Tidlund's recent sale of CompX International Inc. (NYSE:CIX) shares might raise eyebrows, it's essential to consider the broader financial context of the company. According to InvestingPro data, CompX International has demonstrated strong performance over the past year, with a 51.31% price total return. This impressive growth aligns with an InvestingPro Tip highlighting the company's high return over the last year.
Moreover, CompX International boasts a solid dividend yield of 4.14%, with its last ex-dividend date on September 6, 2024. This is particularly noteworthy given another InvestingPro Tip, which reveals that the company has maintained dividend payments for 26 consecutive years. This long-standing commitment to shareholder returns may provide some reassurance to investors in light of the director's stock sale.
Despite a slight revenue decline of 4.68% in the last twelve months as of Q3 2024, CompX International maintains a healthy financial position. The company's liquid assets exceed short-term obligations, as noted in an additional InvestingPro Tip. This financial stability, coupled with profitability over the last twelve months, suggests that the company's fundamentals remain strong despite the recent insider sale.
For investors seeking a more comprehensive analysis, InvestingPro offers 4 additional tips that could provide further insights into CompX International's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.